CD274 and neoplasm: The results suggested that, similar to the PD-L1 aptamer, BSA-Apt could also enhance the PBMC-induced cytotoxicity to tumor cells in vitro, presumably by antagonizing the PD-1/PD-L1 mediated immunosuppressive effects.